Biofrontera Statements
BF
Data from Biofrontera`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
USD - US dollar
Last reporting period:
30 Sep, 2024
Next reporting period:
29 Dec, 2024
Report frequency:
Quarterly
Earnings release date:
13 Nov, 2024
Expected release date:
—
Biofrontera Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
9.012
15 %
100
4.877
54.1
4.135
18.2 %
45.9
0.669
7.4
8.426
93.5
9.095
6.2 %
100.9
-4.96
2.2 %
-55.04
0.006
0.07
-0.712
-7.9
-5.666
-2290.7 %
-62.9
0.003
0.03
-5.669
-2105.8 %
-62.9
-0.982
5.774
7.839
-0.9 %
100
4.342
55.4
3.497
-7.9 %
44.6
0.621
7.9
7.947
101.4
8.568
-7.5 %
109.3
-5.071
7.2 %
-64.7
-0.61
-7.8
5.444
69.4
-0.237
97.7 %
-3.02
0.02
0.3
-0.257
97.5 %
-3.3
-0.05
5.091
7.912
-25.3 %
100
4.116
52
3.796
-27.4 %
48
0.017
0
9.25
116.9
9.263
2.2 %
116.9
-5.467
-42.7 %
-68.9
-1.404
-17.7
-3.249
-41.06
-10.436
-396.5 %
-131.9
0.001
0.01
-10.437
-396 %
-131.9
-2.88
3.624
10.596
19.1 %
100
5.368
50.7
5.228
21.3 %
49.3
—
0
9.06
85.5
9.06
1.8 %
85.5
-3.832
16.5 %
-36.2
-0.998
-9.4
0.998
9.4
3.52
155.5 %
33.2
-0.006
-0.06
3.526
155.6 %
33.3
2.28
1.546
8.9
52.1 %
100
4.59
51.6
4.31
45.6 %
48.4
—
0
8.69
97.6
8.9
-22.9 %
100
-4.59
46.5 %
-51.6
-2.35
-26.4
0.63
7.1
-6.34
35.4 %
-71.2
—
0
-6.34
35.6 %
-71.2
-4.64
1.37
5.85
-33 %
100
2.89
49.4
2.96
-28.5 %
50.6
—
0
11.44
195.6
11.54
35.6 %
197.3
-8.58
-96.3 %
-146.7
-1.56
-26.7
0.44
7.5
-9.82
-31.5 %
-167.9
0.01
0.2
-9.84
-31.6 %
-168.2
-7.23
1.36
8.73
-13.9 %
100
4.6
52.7
4.14
-15.3 %
47.4
—
0
8.71
99.8
8.51
-19 %
97.5
-4.37
22.2 %
-50.06
-2.98
-34.1
1
11.5
-7.47
-168.7 %
-85.6
0.01
0.1
-7.48
-168.1 %
-85.7
-5.62
1.33
10.14
134.7 %
100
5.26
51.9
4.89
132.9 %
48.2
—
0
10.21
100.7
10.5
83.2 %
103.6
-5.62
-54.4 %
-55.4
1.71
16.9
1.12
11
-2.78
-8.2 %
-27.4
—
0
-2.79
-8.6 %
-27.5
-2.15
1.29
4.32
-3.1 %
100
2.23
51.6
2.1
10.5 %
48.6
—
0
7.94
183.8
5.73
-29.4 %
132.6
-3.64
41.4 %
-84.3
-0.09
-2.08
1.16
26.9
-2.57
-202.4 %
-59.5
—
0
-2.57
-202.4 %
-59.5
-2.26
1.14
4.46
-54.3 %
100
2.55
57.2
1.9
-58.7 %
42.6
—
0
10.02
224.7
8.12
5.3 %
182.1
-6.21
-99.7 %
-139.2
-0.04
-0.9
5.4
121.1
-0.85
-115.2 %
-19.06
—
0
-0.85
-115.3 %
-19.06
-0.9
0.94
9.75
6.3 %
100
5.15
52.8
4.6
4.5 %
47.2
—
0
7.71
79.1
7.71
24.8 %
79.1
-3.11
-74.7 %
-31.9
-0.03
-0.3
8.73
89.5
5.59
138.6 %
57.3
0.03
0.3
5.56
138.3 %
57
6.46
0.86
9.17
111.8 %
100
4.77
52
4.4
115.7 %
48
—
0
9.28
101.2
6.18
-65.6 %
67.4
-1.78
88.8 %
-19.4
-0.09
-1
-12.53
-136.6
-14.5
9.4 %
-158.1
0.01
0.1
-14.51
9.4 %
-158.2
-25.91
0.56
4.33
-26.1 %
100
2.29
52.9
2.04
-25.8 %
47.1
—
0
17.25
398.4
17.95
187.7 %
414.5
-15.91
-354.6 %
-367.4
-0.09
-2.08
0.19
4.4
-16.01
-342.3 %
-369.7
0.01
0.2
-16.01
-337.4 %
-369.7
-40.03
0.4
5.86
23.6 %
100
3.11
53.1
2.75
26.7 %
46.9
—
0
5.75
98.1
6.24
15.1 %
106.5
-3.5
-7.7 %
-59.7
-0.09
-1.5
0.16
2.7
-3.62
-2.5 %
-61.8
0.04
0.7
-3.66
-3.7 %
-62.5
-9.15
0.4
4.74
-44.7 %
100
2.57
54.2
2.17
-47.7 %
45.8
—
0
4.92
103.8
5.42
33.2 %
114.3
-3.25
-4162.5 %
-68.6
-0.08
-1.7
0.08
1.7
-3.53
-1757.9 %
-74.5
—
0
-3.53
-1757.9 %
-74.5
-8.84
0.4
8.57
163.7 %
100
4.42
51.6
4.15
85.3 %
48.4
—
0
4.16
48.5
4.07
-7.7 %
47.5
0.08
103.7 %
0.9
-0.76
-8.9
0.76
8.9
-0.19
93.5 %
-2.2
—
0
-0.19
93.6 %
-2.2
-0.47
0.4
3.25
-29.7 %
100
1.01
31.1
2.24
—
68.9
—
0
4.3
132.3
4.41
-22.9 %
135.7
-2.16
38.1 %
-66.5
-0.74
-22.8
0.16
4.9
-2.92
28.8 %
-89.8
0.06
1.8
-2.99
27.1 %
-92
-7.46
0.4
4.62
—
100
2.39
51.7
2.24
—
48.5
—
0
5.98
129.4
5.72
—
123.8
-3.49
—
-75.5
-0.66
-14.3
0.35
7.6
-4.1
—
-88.7
—
0
-4.1
—
-88.7
-10.26
0.4